Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Genomic tests

New options in breast cancer treatment

    • Congress Reports
    • Gynecology
    • Oncology
    • RX
  • 2 minute read

A panel on the effect of the Oncotype DX® genomic test on breast cancer was held in Zurich on March 13 with representatives from various European countries. The event was also broadcast via live webcast. What this test is all about and how it affects current breast cancer therapy will be shown below.

Individualized medicine, or precision medicine, enables physicians to diagnose disease more accurately, predict disease susceptibility more adequately, and use and dose administered medications more efficiently. This was brought to the attention of Steve Shak, moderator of the breast cancer panel in Zurich and co-founder of Genomic Health.

Genomic tests look at groups of genes and determine how active they are acting in a tumor. The Oncotype Dx® test determines the activity of 21 genes within a tumor sample that influence the likelihood of whether and how breast cancer will spread and respond to treatment. The test gives a pattern that allows the determination of a recurrence rate on a scale of 1 to 100.

In this context, personalized medicine ensures that the available budget is used more effectively: With the help of this genomic test, it should be possible to determine which patients need costly chemotherapy and which do not.

Fewer chemotherapies

In 30% of a total of over 5000 women tested, the said test resulted in a change of decision regarding the treatment method. According to Shak, women could also be treated with hormonal therapy based on this genomic test instead of having to undergo expensive chemotherapy. The Oncotype DX® test caused a significant decrease in the overall use of chemotherapy. According to Shak, being able to bypass the serious consequences of chemotherapy underscores the importance and potential of the alternative treatment method using Oncotype DX® testing. Further study results confirming the efficiency of the test remain to be seen.

Demet Bicer

Source: Genomic Health European Media Conference, March 13, Radisson Blu Hotel, Zurich Airport.

Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Breast Cancer
  • Genomic tests
Previous Article
  • Motion analysis in pediatric orthopedics

Use and application of instrumental 3D gait analysis

  • Education
  • Orthopedics
  • Pediatrics
  • RX
View Post
Next Article
  • Diabetes during pregnancy

Which preparation helps?

  • Congress Reports
  • Endocrinology and Diabetology
  • Gynecology
  • RX
View Post
You May Also Like
View Post
  • 45 min
  • Psychedelics and related drug classes

Ritual, party or new therapy? Psychedelics and more: clinically illuminated

    • CME continuing education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 4 min
  • Acute sinusitis: real-world study on first-line therapy

Focusing on a rational therapeutic approach beyond antibiotics

    • Education
    • General Internal Medicine
    • Infectiology
    • ORL
    • Pharmaceutical medicine
    • Pneumology
    • RX
    • Studies
View Post
  • 6 min
  • DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline

Stroke prevention for atrial fibrillation 2025

    • Cardiology
    • Emergency and intensive care medicine
    • Endocrinology and Diabetology
    • Neurology
    • RX
    • Studies
View Post
  • 7 min
  • Prurigo nodularis and AD

Effective itch relief through inhibition of the IL-31 signaling pathway

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • From symptom to diagnosis

Abdominal pain – Hernias

    • Cases
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Radiology
    • RX
    • Surgery
    • Urology
View Post
  • 5 min
  • "Survey of Health, Ageing and Retirement in Europe" (SHARE)

Analysis of polypharmacy in ≥65-year-olds

    • General Internal Medicine
    • Geriatrics
    • Pharmacology and toxicology
    • Practice Management
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 8 min
  • Atopic dermatitis

From skin barrier disorder to atopic march?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Infectiology
    • RX
    • Studies
View Post
  • 8 min
  • New perspectives for clinics and research

Ageing, cellular senescence and Parkinson’s disease

    • Education
    • Geriatrics
    • Neurology
    • RX
Top Partner Content
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Ritual, party or new therapy? Psychedelics and more: clinically illuminated
  • 2
    Drug therapy – Update 2025
  • 3
    Colorectal cancer screening – an update
  • 4
    Aligning care with the patient
  • 5
    Participatory decision-making using the example of diets for type 1 diabetes

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.